{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:58:18Z","timestamp":1757624298795,"version":"3.44.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.dadr.2023.100158","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T02:52:31Z","timestamp":1681181551000},"page":"100158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0230-9373","authenticated-orcid":false,"given":"Wilfrid No\u00ebl","family":"Raby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrios","family":"Milliaressis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Jean","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cale","family":"Basaraba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances R.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Church","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Pavlicova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward V.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2023.100158_bib0001","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/frne.1994.1013","article-title":"Regulation of ACTH secretion during chronic stress","volume":"15","author":"Aguilera","year":"1994","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.dadr.2023.100158_bib0002","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-0115(00)00196-8","article-title":"Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implication for stress adaptation","volume":"96","author":"Aguilera","year":"2000","journal-title":"Regul. Peptides."},{"key":"10.1016\/j.dadr.2023.100158_bib0003","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/bip.20980","article-title":"Delivery of peptides to the brain: emphasis on therapeutic developments","volume":"90","author":"Banks","year":"2008","journal-title":"Biopolymers"},{"issue":"1\u20132","key":"10.1016\/j.dadr.2023.100158_bib0004","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drugalcdep.2010.04.006","article-title":"A placebo controlled trial of memantine for cocaine dependence with high value voucher incentives during a pre-randomization lead-in period","volume":"111","author":"Bisaga","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.dadr.2023.100158_bib0005","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nature Neurosci."},{"key":"10.1016\/j.dadr.2023.100158_bib0006","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00224932","article-title":"Intra- and extra-hypothalamic vasopressin and oxytocin pathways in the rat. Pathways to the limbic system, medulla oblongata and spinal cord","volume":"192","author":"Buijs","year":"1978","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.dadr.2023.100158_bib0007","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1360-0443.1998.9357137.x","article-title":"Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram","volume":"93","author":"Carroll","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2023.100158_bib0008","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007380.pub3","article-title":"Efficacy of psychostimulant drugs for cocaine dependence","volume":"2","author":"Castels","year":"2010","journal-title":"Cochrane Database Syst. Rev"},{"key":"10.1016\/j.dadr.2023.100158_bib0009","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.psyneuen.2011.03.003","article-title":"Neuroanatomical evidence for reciprocal regulation of the corticotropin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: implications for balancing stress and affect","volume":"36","author":"Dabrowska","year":"2011","journal-title":"Psychoneuroendocrinol"},{"key":"10.1016\/j.dadr.2023.100158_bib0010","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1176\/appi.ajp.2019.18101123","article-title":"A single ketamine infusion combined with Mindfullness-Based Behavioral Modification to treat cocaine dependence: a randomized clinical trial","volume":"176","author":"Dakwar","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.dadr.2023.100158_bib0011","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000125712","article-title":"Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats","volume":"53","author":"De Goeij","year":"1991","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.dadr.2023.100158_bib0012","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharmaceutical Sci."},{"key":"10.1016\/j.dadr.2023.100158_bib0013","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/B978-0-12-420118-7.00006-8","article-title":"The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals","volume":"69","author":"Fox","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.dadr.2023.100158_bib0014","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/299355a0","article-title":"Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin","volume":"299","author":"Gilles","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.dadr.2023.100158_bib0015","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nn.3465","article-title":"Fear-enhancing effects of septal oxytocin receptors","volume":"16","author":"Guzman","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.dadr.2023.100158_bib0016","first-page":"76","article-title":"Agonist-like pharmacotherapy for stimulant dependence: preclinical human laboratory and clinical studies","volume":"2","author":"Herin","year":"2010","journal-title":"Addict. Rev."},{"key":"10.1016\/j.dadr.2023.100158_bib0017","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/appi.ajp.2007.05030503","article-title":"Stress, dysregulation of drug reward pathways, and the transition to drug dependence","volume":"164","author":"Koob","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.dadr.2023.100158_bib0018","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.neuropharm.2013.05.024","article-title":"Addiction as a stress surfeit disorder","volume":"76","author":"Koob","year":"2014","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.dadr.2023.100158_bib0019","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0306-4530(98)00064-X","article-title":"Oxytocin and addiction: a review","volume":"23","author":"Kovacs","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.dadr.2023.100158_bib0020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0924-9338(97)83296-8","article-title":"The MINI International Neuropsychiatric Interview. A short diagnostic structured interview: reliability and validity according to the CIDI","volume":"12","author":"Lecrubier","year":"1997","journal-title":"Eur. Psychiatry"},{"issue":"8","key":"10.1016\/j.dadr.2023.100158_bib0021","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/FBP.0000000000000258","article-title":"Oxytocin for the treatment of drug and alcohol use disorders","volume":"27","author":"Lee","year":"2016","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.dadr.2023.100158_bib0022","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1038\/s41467-020-15942-1","article-title":"Labeled oxytocin administered via the intranasal route reaches the brain in rhesus macaques","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.dadr.2023.100158_bib0023","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0306-4530(01)00018-X","article-title":"Inhibitory effects of oxytocin on corticotrope function in humans: are vasopressin and oxytocin ying-yang hormones?","volume":"26","author":"Legros","year":"1982","journal-title":"Psychoneuroendocrinol"},{"issue":"1","key":"10.1016\/j.dadr.2023.100158_bib0024","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1210\/jcem-58-1-105","article-title":"Dose-response relationship between plasma oxytocin and cortisol and adrenocorticotropin concentrations during oxytocin infusion in normal men","volume":"58","author":"Legros","year":"1984","journal-title":"J. Clin. Endocrinol Metab."},{"key":"10.1016\/j.dadr.2023.100158_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107700","article-title":"Extended release mixed amphetamine salts and topiramate for cocaine dependence: a randomized clinical replication trial with frequent users","volume":"206","author":"Levin","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.dadr.2023.100158_bib0026","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jcem-60-1-53","article-title":"Oxytocin does not influence adrenocorticotropin secretion in man","volume":"60","author":"Lewis","year":"1985","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.dadr.2023.100158_bib0027","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0306-4530(97)00045-0","article-title":"Effects of stress and glucocorticoids on CNS oxytocin receptor binding","volume":"22","author":"Liberzon","year":"1997","journal-title":"Psychoneuroendocrinol"},{"key":"10.1016\/j.dadr.2023.100158_bib0028","first-page":"2183","volume":"130","author":"Link","year":"1992","journal-title":"respectively. Endocrinology"},{"issue":"10","key":"10.1016\/j.dadr.2023.100158_bib0029","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1210\/jc.2013-1992","article-title":"A cellular and molecular basis for the selective desmopressin-induced ACTH release in Cushing's disease patients: key role of the AVP1b receptor and potential therapeutic implications","volume":"98","author":"Luque","year":"2013","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.dadr.2023.100158_bib0030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2826.2012.02303.x","article-title":"Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics","volume":"24","author":"Manning","year":"2012","journal-title":"J. Neuroendocrinol."},{"issue":"3","key":"10.1016\/j.dadr.2023.100158_bib0031","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/157488911796958020","article-title":"Pharmacological strategies against glucocorticoid-mediated brain damage during chronic disorders","volume":"6","author":"Martocchia","year":"2011","journal-title":"Recent Pat CNS Drug Discov"},{"key":"10.1016\/j.dadr.2023.100158_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107797","article-title":"Cocaine use disorder: a look at metabotropic glutamate receptors and glutamate transporters","volume":"221","author":"Niedzelska-Andres","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.dadr.2023.100158_bib0033","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/npp.2014.322","article-title":"Agonist medications for the treatment of cocaine use disorder","volume":"40","author":"Negus","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.dadr.2023.100158_bib0034","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/npp.2017.275","article-title":"Exacerbated cravings in the presence of stress and drug cues in drug-dependent patients","volume":"43","author":"Preston","year":"2018","journal-title":"Neuropsychopharm"},{"key":"10.1016\/j.dadr.2023.100158_bib0035","series-title":"Psychiatry","first-page":"2390","article-title":"Pharmacological treatment of substance abuse disorders","author":"Raby","year":"2008"},{"key":"10.1016\/j.dadr.2023.100158_bib0036","article-title":"Intranasal oxytocin may improve odds of abstinence in cocaine-dependent patients: results from a preliminary study","volume":"2","author":"Raby","year":"2022","journal-title":"Drug Alcohol Dep Rep."},{"issue":"2","key":"10.1016\/j.dadr.2023.100158_bib0037","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4155\/fmc.11.184","article-title":"Agonist replacement therapy for cocaine dependence: a translational review","volume":"4","author":"Rush","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.dadr.2023.100158_bib0038","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1507\/endocrj.44.687","article-title":"Desmopressin stimulation test for diagnosis of ACTH-dependent Cushing's syndrome","volume":"44","author":"Sakai","year":"1997","journal-title":"Endocr J"},{"key":"10.1016\/j.dadr.2023.100158_bib0039","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0143-4179(92)90006-I","article-title":"Effects of cocaine on the contents of neurohypophysial hormones in the plasma and in different brain structures in rats","volume":"23","author":"Sarnyai","year":"1992","journal-title":"Neuropeptides"},{"issue":"4667","key":"10.1016\/j.dadr.2023.100158_bib0040","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/bmj.1.4667.1383","article-title":"Stress and the general adaptation syndrome","volume":"1","author":"Selye","year":"1950","journal-title":"Br. Med. J."},{"key":"10.1016\/j.dadr.2023.100158_bib0041","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biopsych.2015.07.020","article-title":"The social salience hypothesis of oxytocin","volume":"79","author":"Sharnay-Tsoory","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.dadr.2023.100158_bib0042","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1210\/endo.135.5.7956927","article-title":"Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type","volume":"135","author":"Schlosser","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.dadr.2023.100158_bib0043","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.63.3.324","article-title":"Stress-induced cocaine craving and hypothalamo-pituitary-adrenal responses are predictive of cocaine relapse outcomes","volume":"63","author":"Sinha","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.dadr.2023.100158_bib0044","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-2006-944522","article-title":"Effects of chronic alcohol disease on magnocellular and parvocellular hypothalamic neurons in men","volume":"38","author":"Sivukhina","year":"2006","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.dadr.2023.100158_bib0045","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/gps.1161","article-title":"Smell identification test as an indicator of cognitive impairment in Alzheimer's disease","volume":"19","author":"Suzuki","year":"2004","journal-title":"Int J. Geriatric Psychiatry."},{"key":"10.1016\/j.dadr.2023.100158_bib0046","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1172\/JCI200419656","article-title":"The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis reactivity under both stress and resting conditions","volume":"113","author":"Tanoue","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.dadr.2023.100158_bib0048","unstructured":"Tribollet E. 1992. Vasopressin and oxytocin receptors in the rat brain. In: Bjorklund A, Hokfelt T and Kuhar MJ (eds), Handbook of Chemical Neuroanatomy, vol 11: Neuropeptide receptors in the CNS, Elsevier, pp. 289\u2013320."},{"key":"10.1016\/j.dadr.2023.100158_bib0049","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1523\/JNEUROSCI.1544-06.2006","article-title":"Cocaine cues and dopamine in the dorsal striatum: mechanism of craving in cocaine addiction","volume":"26","author":"Volkow","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.dadr.2023.100158_bib0050","unstructured":"www.enzolifesciences.com\/fileadmin\/reports\/Datasheet-ENZ-kit138.pdf."},{"key":"10.1016\/j.dadr.2023.100158_bib0051","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1523\/JNEUROSCI.3432-03.2004","article-title":"Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal axis","volume":"24","author":"Windle","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.dadr.2023.100158_bib0052","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/npp.2011.97","article-title":"Persistent increase in hypothalamic arginine vasopressin gene expression during protracted withdrawal from escalating-dose cocaine in rodents","volume":"36","author":"Zhou","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.dadr.2023.100158_bib0053","first-page":"1","article-title":"Oxytocin reduces cocaine seeking and reverses chronic cocaine-induced changes in glutamate receptor function","volume":"1","author":"Zhou","year":"2014","journal-title":"Int. J. Neuropsychopharmacology"}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724623000288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724623000288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:35:08Z","timestamp":1757421308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724623000288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":52,"alternative-id":["S2772724623000288"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2023.100158","relation":{},"ISSN":["2772-7246"],"issn-type":[{"type":"print","value":"2772-7246"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2023.100158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100158"}}